Innoviva (INVA) Tops Q4 EPS by 7c

Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.6 million versus the consensus estimate of $40.72 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance